<h1>India Boosts API Manufacturing with Rs. 6,940 Crore Incentive Scheme to Strengthen Pharma Sector by 2030.</h1> India, a major global player in pharmaceuticals, is enhancing its Active Pharmaceutical Ingredients (API) manufacturing through government initiatives. The Production Linked Incentive Scheme, with a financial outlay of Rs. 6,940 crores, aims to boost domestic production of critical materials from 2020-21 to 2029-30. Another PLI Scheme for Pharmaceuticals, with a Rs. 15,000 crore budget, supports API and other drug categories from 2020-21 to 2028-29. Additionally, the Promotion of Bulk Drug Parks scheme, with a Rs. 3,000 crore allocation, seeks to establish three parks with world-class infrastructure, running from 2020-21 to 2024-25. These efforts aim to attract investment and strengthen India's pharmaceutical sector.